Gadoterate Meglumine Injection
C16H25GdN4O8·C7H17NO5
753.86
d-Glucitol, 1-deoxy-1-(methylamino)-, [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7,κO10]gadolinate(1-) (1:1);
1-Deoxy-1-(methylamino)-d-glucitol hydrogen [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7,κO10]gadolinate(1-) [92943-93-6]
d-Glucitol, 1-deoxy-1-(methylamino)-, [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7,κO10]gadolinate(1-) (1:1);
1-Deoxy-1-(methylamino)-d-glucitol hydrogen [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7,κO10]gadolinate(1-) [92943-93-6]
DEFINITION
Gadoterate Meglumine Injection is a sterile solution of Gadoterate Meglumine in Water for Injection. It contains NLT 90.0% and NMT 110.0% of the labeled amount of gadoterate meglumine (C16H25GdN4O8·C7H17NO5).